Advertisement

Topics

Light-activated viral nanoparticle for treatment of choroidal melanoma meets early study endpoints

12:30 EST 12 Nov 2017 | Healio

Carol L. Shields
NEW ORLEANS — Choroidal melanoma has a high unmet medical need, according to Carol L. Shields, MD, and results of an early-stage study of a light-activated viral nanoparticle lend encouragement that a therapy may be developed to meet that need.
At Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting,
Shields delivered interim results from the phase 1b/2 open-label ascending single and repeat dose clinical trial designed to evaluate the safety of AU-011 (Aura Biosciences) for treatment of small to medium choroidal melanoma.
Choroidal melanoma is a

Original Article: Light-activated viral nanoparticle for treatment of choroidal melanoma meets early study endpoints

NEXT ARTICLE

More From BioPortfolio on "Light-activated viral nanoparticle for treatment of choroidal melanoma meets early study endpoints"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....